Blank Overlay Used To Show Alert Messages Automatically
You are about to leave bloomssyndromeassociation.com.
Click Cancel to return or OK to continue.
All conference sessions will be held at the Embassy Suites at Chicago O'Hare Rosemont in the Salon ABC Meeting Room.
Hofbrauhaus Chicago5500 Park PlaceRosemont, Illinois 60018(walking distance from conference hotel)
Embassy Suites – Atrium Grove
Embassy Suites – Salon ABC Meeting Room(Salon A-only pictured above)
Dr. Cunniff will provide an overview of the Bloom’s Syndrome Registry, including the number of registrants, the kind of information that is contained in the Registry, and the samples that have been collected. He will provide an overview of the Health Supervision Recommendations for people with Bloom syndrome that are soon to be published in the American Journal of Medical Genetics and will update attendees on activities that are currently underway at the Registry and those that are planned for the near future.
Dr. Levy will discuss common ways that cancers are treated in the general population and how these treatment strategies have been modified for people with Bloom’s syndrome. She will provide information on which types of chemotherapy are believed to be well tolerated by people with Bloom syndrome and those that may be associated with problem side effects or long-term risks. She will also discuss new treatment approaches that are being developed and the ways these new treatments may be useful for people with Bloom syndrome.
Dr. Plon will use her extensive background in cancer surveillance to discuss how we can best detect cancer at its earliest stages, when treatment is most successful. She will review information on how this is being done in conditions similar to Bloom’s syndrome, where a genetic change causes significantly increased risks, compared to the general population. She will also provide input on how best to study the current approaches to cancer surveillance in people with Bloom’s syndrome and to measure their effectiveness.
Dr. Vogiatzi will review her experience in screening, diagnosis and treatment of endocrine abnormalities in people with Bloom syndrome. These issues will include growth problems, thyroid abnormalities, type 2 diabetes, cholesterol and triglyceride abnormalities, puberty and fertility. She will provide information on treatment of these endocrine issues, including use of growth hormone.
Dr. Schussler will provide background information on the immune system and how it does its job. She will discuss the basic parts of the immune system, including immune cells such as T and B-cells, as well as immunoglobulins and how they protect us from infection. She will describe what is currently known about the range of immune abnormalities that have been reported in people with Bloom syndrome. She will also give information about what kind of immune testing may be most helpful, when referral should be made to an immunologist, and how best to treat recurrent infections, including when immunoglobulin therapy is indicated.
Ms. Grossman has recorded a video presentation that provides her perspective as a person with Bloom’s syndrome and as the facilitator for Bloom’s Connect. Panelists will respond to the issues raised and will provide their own unique perspective as a person with Bloom’s syndrome or a family member of someone with Bloom’s syndrome.
As CEO of Global Genes, Ms. Boice works to “build awareness, educate the global community, and provide critical connections and resources that equip advocates to become activists for their disease.” She will share her experience in founding Global Genes and will discuss successful strategies for engagement of patients, patient support organizations, and their partners.
Dr. Ellis and Dr. Groden have been at the forefront of Bloom’s syndrome research and have been responsible for much of what is known about the fundamental functions of the BLM gene and how BLM gene abnormalities cause medical problems. Building upon their own success in genetic investigation, they will provide their recommendations for future research that will have the highest impact.
Representatives from the Bloom’s Syndrome Association, Bloom’s Syndrome Registry, Bloom Syndrome Foundation (Europe), and the Bloom’s Syndrome Nanocourse group will reflect on the themes of the meeting and discuss ways to improve our understanding of Bloom’s syndrome and to apply this knowledge for better health and social outcomes.